U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06971289) titled 'Development and Characterization of Functional Assays for the Analysis of Inflammation Signaling Pathways' on May 06.
Brief Summary: Auto-inflammatory diseases are part of a heterogeneous group of illnesses manifested by an inflammatory reaction in its initial phase (innate immunity) that is activated inappropriately: either because the reaction is too strong, or because it is not justified (e.g. in the absence of infection).
Autoinflammatory diseases are often initially described as genetic in origin (i.e. hereditary or familial), and preferentially affect children or young adults. However, the preponderance of auto-inflammation as...